BioAge Labs BIOA
NASDAQ BIOA
$6.65 -0.16 (-2.35%)
As of: Oct 2, 2026 · 2:32 PM EDT

BioAge Labs (BIOA) Return on Assets [ROA] (2024 - 2026)

Updated

BioAge Labs' Return on Assets [ROA] came in at -23.63% for Q2 2026, up 0.16 percentage points from -23.79% a year earlier and up 2.23 percentage points from the prior quarter.

Analysis

BioAge Labs (BIOA) Return on Assets [ROA] (2024 - 2026) Analysis & Trends

For FY2025, BioAge Labs' Return on Assets [ROA] was -24.62%, up 12.31 percentage points from FY2024.

  • Going back by year, Return on Assets [ROA] was -36.93% in FY2024.
  • The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] since Q1 2025.
  • Business Quant data shows BIOA's Return on Assets [ROA] at -25.86% (Q1 2026), -26.80% (Q4 2025) and -24.31% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 BioAge Labs 324.56 Mn 324.56 Mn -14.23 Mn -23.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.63%
Mar 31, 2026 -25.86%
Dec 31, 2025 -26.80%
Sep 30, 2025 -24.31%
Jun 30, 2025 -23.79%
Mar 31, 2025 -20.28%
Dec 31, 2024 -20.39%
API Access

BioAge Labs Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BIOA&period=max&api_key=YOUR_API_KEY